The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial
Clinical trial NCT07114640 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07114640
- Sponsor
- Far Eastern Memorial Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-07
- Primary completion
- 2028-12-31
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.